Actively Recruiting

Phase Not Applicable
Age: 61Years +
All Genders
NCT07547007

Benefits of a 6-month, Individualized, Hybrid, "Real-life" Adapted Physical Activity Program on the Quality of Life of Patients Treated for Multiple Myeloma

Led by Centre Hospitalier Metropole Savoie · Updated on 2026-04-23

86

Participants Needed

2

Research Sites

131 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate the effect of a long-term, individualized, hybrid adapted physical activity program on the quality of life of patients with multiple myeloma. The main question it aims to answer are : Does this logn term, individualized and hybrid adapted physical activity program improve quality of life in multiple myeloma patient ? What are the effects of this program on effort tolerance, pain, muscular mass, osteolytic lesions, tolerance to treatment, response to treatment? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\]. Participants will be randomised in 2 groups. * control group: patients will receive only advices about physical activities benefit * interventional group: This group will be offered a program of adapted physical activities mixing sessions at home (remote) and sessions at the hospital (in person).

CONDITIONS

Official Title

Benefits of a 6-month, Individualized, Hybrid, "Real-life" Adapted Physical Activity Program on the Quality of Life of Patients Treated for Multiple Myeloma

Who Can Participate

Age: 61Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Newly diagnosed or relapse multiple myeloma patients over 60 years old who are not eligible for transplant
  • Patients on first to fourth line of treatment started within the last 3 months
  • Patients receiving systemic treatment with hospital visits at least twice a month during the first 3 months and at least once a month during the following 3 months
Not Eligible

You will not qualify if you...

  • Severe cardiac amyloidosis
  • Absolute contraindication to physical activity
  • Inability to comply with the study protocol
  • Not a French speaker
  • Under legal guardianship or curatorship
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

CH Annecy Genevois

Annecy, France, 74374

Actively Recruiting

2

CH Métropole Savoie

Chambéry, France, 73000

Actively Recruiting

Loading map...

Research Team

C

Charlene DUPRE

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here